Jefferies Group LLC Karyopharm Therapeutics Inc. Call Options Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$4.15 - $8.37 $41,500 - $83,699	-10,000 Closed	0 $0
Q1 2022 Sep 21, 2023	BUY	$5.91 - $14.38 $59,100 - $143,800	10,000 New	10,000 $73,000
Q1 2022 May 16, 2022	BUY	$5.91 - $14.38 $59,100 - $143,800	10,000 New	10,000 $74,000
Q2 2019 Aug 14, 2019	SELL	$4.32 - $6.43 $320,112 - $476,463	-74,100 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$4.12 - $10.25 $305,292 - $759,525	74,100 New	74,100 $433,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $64.6M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.